Fabtech Cleanrooms books ₹35.60 crore in new orders for September 2026
- Fabtech Cleanrooms secured ₹35.60 crore in new orders in September 2026
- Total order book stands at ₹468.18 crore as of September 30, 2026
- Pharma and Renewable Energy dominate the backlog with ₹217.15 crore and ₹195.44 crore respectively
- Orders under active consideration total ₹394.55 crore, led by Pharma opportunities

*this image is generated using AI for illustrative purposes only.
Fabtech Technologies Cleanrooms Ltd secured consolidated orders worth ₹35.60 crore during September 2026. The company reported a total order book of ₹468.18 crore as of September 30, 2026, reflecting continued demand across key industrial sectors.
The new order inflow was distributed across multiple verticals. The Others category contributed the largest share at ₹21.04 crore, followed by Pharma at ₹7.22 crore, Data Centres at ₹4.83 crore, and Semiconductors at ₹2.51 crore. From a product perspective, HVAC Systems accounted for ₹28.26 crore of the new bookings, while Cleanroom Partitions contributed ₹7.34 crore.
Order Book Composition
As of the end of September 2026, the company’s consolidated order book stood at ₹468.18 crore. The portfolio is heavily weighted towards Renewable Energy and Pharmaceutical sectors, which together constitute the majority of the backlog.
| Sector | Order Book Value (₹ crore) |
|---|---|
| Pharma | 217.15 |
| Renewable Energy | 195.44 |
| Data Centres | 26.91 |
| Others | 26.69 |
| Semiconductors | 1.99 |
| Total | 468.18 |
The Others category in the order book includes Automotive Electronics, Commercial, FMCG, and miscellaneous industries.
Pipeline and Strategic Focus
Orders under active consideration total ₹394.55 crore, indicating a robust near-term pipeline. Major opportunities in this pipeline are concentrated in Pharma (₹215.28 crore) and Renewable Energy (₹146.50 crore), with smaller contributions from Data Centres (₹17.17 crore) and Others (₹15.60 crore).
The company stated that it continues to strengthen its presence across high-growth sectors including Renewable Energy, Pharmaceuticals, Data Centers, Semiconductors, and Nutraceuticals. This diversification reflects its capability to deliver integrated cleanroom and HVAC solutions for complex manufacturing environments.
What the Numbers Show
A comparison between the current order book and the active pipeline reveals a significant concentration in the Pharmaceutical sector. Pharma accounts for 46% of the existing order book (₹217.15 crore out of ₹468.18 crore) and 54% of the orders under consideration (₹215.28 crore out of ₹394.55 crore). This suggests that future revenue visibility is heavily dependent on the conversion of pharma-related projects, highlighting a sector-specific dependency despite the company's stated multi-sector strategy.
Historical Stock Returns for Fabtech Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -5.80% | -8.05% | -0.08% | +92.32% | +18.60% | +167.88% |
How will Fabtech manage execution risks and supply chain constraints given the heavy concentration of its order book in the Pharmaceutical sector?
What specific capacity expansion plans or capital expenditures are required to support the conversion of the ₹394.55 crore pipeline into confirmed orders?
How does the current backlog composition align with Fabtech's stated strategic goal of diversifying into high-growth sectors like Semiconductors and Data Centres?

































